Genky DrugStores Co., Ltd.

9267.TJapan

15 filed reports · 223 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

¥221B

FY2026 · to Jun 20, 2026

up +9.9% vs ¥201B

Annual report

Net income

¥7.88B

FY2026 · to Jun 20, 2026

up +11.4% vs ¥7.07B

Annual report

Operating income

¥11B

FY2026 · to Jun 20, 2026

up +13.7% vs ¥9.66B

Annual report

Latest half year

Revenue

¥109B

H1 FY2026 · to Dec 20, 2025

up +10.6% vs ¥98.8B

Half-year report

Net income

¥4.02B

H1 FY2026 · to Dec 20, 2025

up +23.0% vs ¥3.27B

Half-year report

Operating income

¥5.72B

H1 FY2026 · to Dec 20, 2025

up +24.4% vs ¥4.6B

Half-year report

Filed reports

15 reports · Dec 2021 to Jun 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Annual · annual securities reportEDINET51,504Jun 2022 to Jun 2026
Half Year · quarterly securities reportEDINET3519Dec 2021 to Dec 2023
Q3 · quarterly securities reportEDINET3412Mar 2022 to Mar 2024
Half Year · half-year securities reportEDINET2424Dec 2024 to Dec 2025
Q1 · quarterly securities reportEDINET2284Sep 2022 to Sep 2023

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026annual securities report2026-06-202026-09-09507Open
FY2026 H1half-year securities report2025-12-202026-01-30248Open
FY2025annual securities report2025-06-202025-09-10248Open
FY2025 H1half-year securities report2024-12-202025-01-31176Open
FY2024annual securities report2024-06-202024-09-13250Open
FY2024 Q3quarterly securities report2024-03-202024-05-02168Open
FY2024 H1quarterly securities report2023-12-202024-02-02177Open
FY2024 Q1quarterly securities report2023-09-202023-11-02163Open
FY2023annual securities report2023-06-202023-09-20248Open
FY2023 Q3quarterly securities report2023-03-202023-05-02121Open
FY2023 H1quarterly securities report2022-12-202023-02-02169Open
FY2023 Q1quarterly securities report2022-09-202022-11-02121Open

Financial data

223 concepts · 3,143 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

GAAP221 concepts · 3,133 facts · Jun 2020 to Jun 2026

  • EPS (Basic)45 · Jun 2020 to Jun 2026
  • Equity-to-asset ratio, Key financial data37 · Jun 2020 to Jun 2026
  • Net Assets37 · Jun 2020 to Jun 2026
  • Ordinary profit (loss), Key financial data37 · Jun 2020 to Jun 2026
  • Revenue37 · Jun 2020 to Jun 2026
  • Total Assets37 · Jun 2020 to Jun 2026
  • EPS (Diluted)35 · Dec 2020 to Jun 2026
  • Net assets, Key financial data34 · Jun 2020 to Jun 2026
  • Accounts receivable - trade32 · Jun 2021 to Jun 2026
  • Capital surplus32 · Jun 2021 to Jun 2026
  • Cash and deposits32 · Jun 2021 to Jun 2026
  • Income taxes payable32 · Jun 2021 to Jun 2026
  • Investments and other assets32 · Jun 2021 to Jun 2026
  • Other-CA32 · Jun 2021 to Jun 2026
  • Retained Earnings (Accumulated Deficit)32 · Jun 2021 to Jun 2026
  • Share acquisition rights32 · Jun 2021 to Jun 2026
  • Share capital32 · Jun 2021 to Jun 2026
  • Shareholders' equity32 · Jun 2021 to Jun 2026
  • Total assets, Key financial data32 · Jun 2021 to Jun 2026
  • Total Current Assets32 · Jun 2021 to Jun 2026
  • Total Current Liabilities32 · Jun 2021 to Jun 2026
  • Total Equity and Liabilities32 · Jun 2021 to Jun 2026
  • Total Liabilities32 · Jun 2021 to Jun 2026
  • Total Noncurrent Assets32 · Jun 2021 to Jun 2026

Segment2 concepts · 10 facts · Jun 2022 to Jun 2026

  • Average number of temporary employees5 · Jun 2022 to Jun 2026
  • Number of employees5 · Jun 2022 to Jun 2026

Segments

10 facts

Figures broken down by business line, region, product or another axis the company reports on.

Operating segments1 member · 10 facts

  • CorporateSharedMember10 · Jun 2022 to Jun 2026

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of Genky DrugStores Co., Ltd. (9267.T) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.

Genky DrugStores Co., Ltd. (9267.T): FY2026 revenue ¥221B · FactIQ